Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Moderna, Inc.
  6. Financials
    MRNA   US60770K1079

MODERNA, INC.

(MRNA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization1 5 0236 51841 340167 140--
Entreprise Value (EV)1 4 3985 54836 842155 192145 797141 545
P/E ratio -12,5x-12,6x-53,3x16,5x23,6x83,9x
Yield ------
Capitalization / Revenue 37,2x108x51,5x8,74x10,6x20,5x
EV / Revenue 32,6x92,1x45,9x8,12x9,22x17,4x
EV / EBITDA -11,3x-10,8x-50,3x11,3x14,5x30,8x
Price to Book -6,14x16,3x11,7x7,89x6,24x
Nbr of stocks (in thousands) 328 948333 250395 710401 528--
Reference price (USD) 15,319,6104416416416
Announcement Date 03/06/201902/26/202002/25/2021---
1 USD in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales1 13560,280319 11715 8128 151
EBITDA1 -388-515-73213 77710 0594 593
Operating profit (EBIT)1 -413-546-76312 91210 0053 236
Operating Margin -306%-906%-95,0%67,5%63,3%39,7%
Pre-Tax Profit (EBT)1 -384-515-74512 53310 6482 320
Net income1 -402-514-74710 7257 6892 278
Net margin -298%-854%-93,0%56,1%48,6%27,9%
EPS2 -1,22-1,55-1,9625,317,64,96
Dividend per Share2 ------
Announcement Date 03/06/201902/26/202002/25/2021---
1 USD in Million
2 USD
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2020 Q3 2020 Q4 2021 Q1 2021 Q2 2021 Q3 2021 Q4
Net sales1 1585711 9374 2335 9806 799
EBITDA ------
Operating profit (EBIT)1 -235-2751 2662 8584 0824 580
Operating Margin -149%-48,2%65,4%67,5%68,3%67,4%
Pre-Tax Profit (EBT)1 -233-2711 2602 7543 8674 555
Net income1 -234-2721 2212 4673 3293 624
Net margin -148%-47,7%63,0%58,3%55,7%53,3%
EPS2 -0,59-0,692,845,597,578,36
Dividend per Share ------
Announcement Date 10/29/202002/25/202105/06/2021---
1 USD in Million
2 USD
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt1 ------
Net Cash position1 6259714 49811 94821 34325 595
Leverage (Debt / EBITDA) 1,61x1,89x6,15x-0,87x-2,12x-5,57x
Free Cash Flow1 -437-4911 9609 0967 2233 532
ROE (Net Profit / Equities) -39,3%-38,0%-40,0%137%44,4%10,6%
Shareholders' equity1 1 0231 3531 8687 83217 30621 409
ROA (Net Profit / Asset) -25,3%-28,9%-16,7%107%44,5%7,71%
Assets1 1 5911 7764 46310 00317 27429 547
Book Value Per Share2 -3,196,4235,652,866,8
Cash Flow per Share2 -1,01-5,3221,022,51,02
Capex1 10631,667,4379277229
Capex / Sales 78,3%52,4%8,40%1,98%1,75%2,81%
Announcement Date 03/06/201902/26/202002/25/2021---
1 USD in Million
2 USD
Key data
Capitalization (USD) 167 139 957 449
Net sales (USD) 803 395 000
Number of employees 1 300
Sales / Employee (USD) 617 996
Free-Float 90,3%
Free-Float capitalization (USD) 150 972 948 115
Avg. Exchange 20 sessions (USD) 9 820 645 374
Average Daily Capital Traded 5,88%
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA